AcelRx Pharmaceuticals

$1.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-1.14%) As of 10:48 AM EDT today

Why Robinhood?

You can buy or sell ACRX and other stocks, options, and ETFs commission-free!

About ACRX

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. Read More The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA. The listed name for ACRX is AcelRx Pharmaceuticals, Inc. Common Stock.

Employees
99
Headquarters
Redwood City, California
Founded
2005
Market Cap
158.52M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.73M
High Today
$1.77
Low Today
$1.65
Open Price
$1.69
Volume
540.40K
52 Week High
$2.50
52 Week Low
$0.7014

Collections

ACRX Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 9, After Hours

You May Also Like